SonALAsense
Nandini Kandolha has a diverse work experience spanning different industries and roles. Nandini is currently serving as the Chief Financial Officer & Chief Operations Officer at SonALAsense since July 2022. Prior to this, they held the position of Chief Financial Officer at SonALAsense since January 2022.
Before their tenure at SonALAsense, Nandini worked at Solutions On Call South as a Consultant and later became the Chief Executive Officer in 2016. In 2017, they joined Solutions on Call as a Consultant. Nandini also worked as a Consultant at Solutions on Call Soutb from 2016 to 2022.
Nandini's early career includes roles at an unknown company from 2010 to 2016, serving in various unknown positions during that time. Nandini also gained experience at Deloitte & Touche LLP, where they started as an Audit Intern in 2007. Nandini later held the positions of Audit Staff and Senior from 2008 to 2010.
Overall, Nandini Kandolha has held significant leadership and financial positions throughout their career, demonstrating their expertise and versatility in the corporate world.
Nandini Kandolha has a Master's degree in International Studies from the University of St. Thomas (TX) and a Bachelor of Business Administration (BBA) in Accounting from the University of Houston-Downtown. Nandini also holds a certification as a CPA from the Texas Board of Public Accountancy. No specific information regarding the years of completion or the month and year of obtaining the CPA certification is provided.
This person is not in any teams
This person is not in any offices
SonALAsense
SonALAsense develops SDT (Sonodynamic Therapy) intended to turn glioblastoma multiforme (GBM) patients into cancer survivors. It utilizes MRI-guided focused ultrasound (the device) in combination with aminolevulinic acid (a drug) to selectively target and kill tumor cells. Their use of an MRI-guided focused ultrasound device with ALA is a truedrug-device combination, where both the drug and the device are required for a therapeutic effect. SDT has a well-elucidated mechanism of action (creation of reactive oxygen species). The company was founded in 2019 and is based in Berkeley, California.